|
Wednesday June 20, 2018: McGill Thompson House
3650 Mc Tavish St, Montreal, QC H3A 1Y2
|
19:00 - 22:00 |
Welcome Reception
|
|
Thursday June 21, 2018: McGill Faculty Club & Conference Centre
|
07:00 - 08:00 |
Continental Breakfast |
08:00 - 08:15 |
Opening Remarks |
08:15 - 09:00 |
Plenary Speaker 1: Dr. Magnus Ekstrom, Lund University, Sweden
Title: Epidemiology & Burden of Breathlessness |
09:00 - 09:15 |
Coffee Break |
|
Theme 1: Mechanisms of Breathlessness
|
09:15 - 10:00 |
Plenary Speaker 2: Dr. Denis E. O'Donnell, Queen's University, Canada
Title: Pathophysiological Mechanisms of Breathlessness |
10:00 - 10:45 |
Plenary Speaker 3: Dr. Kyle Pattinson, University of Oxford, United Kingdom
Title: Central Mechanisms of Breathlessness |
10:45 - 11:05 |
Speaker: Dr. Andreas von Leupoldt, University of Leuven, Belgium
Title: Psychological Mechanisms of Breathlessness - A Neural Update About Interactions of Affective States and Traits with Breathlessness |
11:05 - 11:15 |
Oral presentation 1
Speaker: Dr. Shakeeb H. Moosavi, Oxford Brookes University, United Kingdom
Title: Thalmic deep brain stimulation relieves hypercapnia-induced air hunger |
11:15 - 11:25 |
Oral presentation 2
Speaker: Michaela Herzog, University of Leuven, Belgium
Title: Seeing others in dyspnea induces vicarious dyspnea in the observer |
11:25 - 11:35 |
Oral presentation 3
Speaker: Dr. Caroline J. Jolley, Kings College London, United Kingdom
Title: Neural respiratory drive and symptoms limiting exercise tolerance in COPD |
11:35 - 11:45 |
Oral presentation 4
Speaker: Dr. Joanna C. Grogono, Oxford Brookes University, United Kingdom
Title: Specificity of dyspnea relief with inhaled furosemide |
11:45 - 11:55 |
Oral presentation 5
Speaker: Thomas Reijnders, University of Leuven, Belgium
Title: Neural processing of respiratory symptoms in patients with COPD |
11:55 - 13:00 |
LUNCH |
|
Theme 2: Measurement of Breathlessness
|
13:00 - 13:45 |
Speakers: Dr. Bob Banzett, Harvard Medical School, USA; Dr. Janelle Yorke, University of Manchester, United Kingdom
Title: Update on the Multidimensional Evaluation of Breathlessness: Merits of the Multidimensional Dyspnea Profile (MDP) and Dyspnoea-12 (D12)
Moderators: Dr. Marie Williams, University of South Australia, Australia; Dr. Miriam Johnson, University of Hull, United Kingdom |
13:45 - 14:05 |
Speaker: Dr. Margaret L. Campbell, Wayne State University, USA
Title: Measurement of Breathlessness in the Intensive Care Unit |
14:05 - 14:25 |
Speaker: Dr. Dennis Jensen, McGill University, Canada
Title: Measurement of Exertional Breathlessness in the Clinical Care Setting of Chronic Pulmonary Disease |
14:25 - 14:45 |
Speaker: Dr. Bob Banzett, Harvard Medical School, USA
Title: Measurement of Breathlessness by Healthcare Professionals in the Hospital Setting |
14:45 - 15:00 |
Coffee Break |
15:00 - 15:45 |
Lightning Round Presentations: 2 slides in 2 minutes!
- Lauren Tracey (McGill University, Canada): Physiological and perceptual responses to exercise according to the locus of symptom limitation in patients with COPD
- Dr. Bob Banzett (Harvard Medical School, USA): Variance among and within individuals of air hunger response during constant mechanical ventilation and graded hypercapnia
- Amar Mainra (McGill University, Canada): Physiological mechanisms of exertional breathlessness relief following bariatric surgery for severe obesity
- Dr. Nicolle J. Domnik (Queen's University, Canada): Ventilatory control characteristics and dyspnea in mild COPD
- Sophie E. Collins (University of Alberta, Canada): Does the carotid chemoreceptor play a role in the potentiated ventilatory and dyspnea response to exercise in chronic heart failure?
- Josef Sucec (University of Leuven, Belgium): Can you inhibit behavioral responses while being breathless?
- Andrew P. Binks (Virgina Tech Carilion School of Medicine, USA): Tidal volume restrictions and hypercapnia produce indistinguishable forms of dyspnea
- Charlotte G. Golding (Oxford Brookes University, United Kingdom): Differential modulation of breathlessness by deep brain stimulation of sub-thalamic and motor thalamic nuclei
- Robert Hallowell (Harvard Medical School, USA): Effect of aerosol furosemide (80 mg) on exercise-induced dyspnea in patients
- Dr. Joanna C. Grogono (Oxford Brookes University, United Kingdom): Effect of breathing pattern on dyspnea relief with inhaled furosemid in heart failure
- Dr. Tony G. Babb (University of Texas Southwester Medical Centre, USA): Multidimensional dyspnea profile in patients referred for cardiopulmonary exercise testing
- Norman R. Morris (Griffith University, Australia): The impact of negative mood on exertional dyspnoea in chronic obstructive pulmonary disease
- Joshua Good (University of Ontario Institute of Technology, Canada): Perceptions of dyspnea and functional fitness among community dwelling older adults with obstructive lung disease
- Joshua Good (University of Ontario Institute of Technology, Canada): Correlates of resting and exertional dyspnea in community dwelling older adults with obstructive lung disease
- Joshua Good (University of Ontario Institute of Technology, Canada): Dyspnea during sprint interval and continuous exercise in adults with exercise-induced bronchoconstriction
- Abebaw M. Yohannes (Azusa Pacific University, USA): Determinants of dyspnea in COPD patients attending pulmonary rehabilitation program
- Carley O'Neill (University of Ontario Institute of Technology, Canada): Perceived dyspnea during high intensity interval exercise and continuous exercise among adults with exercise-induced bronchoconstriction
- Carley O'Neill (University of Ontario Institute of Technology, Canada): The impact of a 6-week high intensity interval exercise intervention on perceived dyspnea among adults with exercise-induced bronchoconstriction
- Dr. Alan Hamilton on behalf of Dr. Francois Maltais (Boehringer Ingelheim, Canada): The effect of tiotropium/olodaterol versus tiotropium on breathlessness during the 3-minute constant-speed shuttle walking test in patients with chronic obstructive pulmonary disease.
|
15:45 - 17:00 |
Poster Viewing & Discussion |
17:00 - 18:00 |
Dyspnea Society Business Meeting |
19:30 - 22:30 |
DINNER (Wienstein & Gavino's) |
|
Friday June 22, 2018: McGill Faculty Club & Conference Centre
|
07:00 - 08:00 |
Continental Breakfast |
|
Theme 3: Management of Breathlessness
|
08:00 - 08:45 |
Plenary Speaker 4: Dr. Sara Booth, University of Cambridge, United Kingdom
Title: Recent Advances in the Pharmacological & Non-Pharmacological Management of Breathlessness |
08:45 - 09:30 |
Plenary Speakers 5 & 6: Dr. Nick Vozoris, University of Toronto, Canada; Dr. Jean Bourbeau, McGill University, Canada
Title: Role of Opioids in the Management of Breathlessness - Pro (Bourbeau) vs. Con (Vozoris) Debate
Moderator(s): TBD |
09:30 - 09:45 |
Coffee Break |
09:45 - 09:55 |
Oral presentation 6
Speaker: Dr. Jennifer Stevens, Harvard Medical School, USA
Title: Patient mortality, readmissions, and resource use associated with dyspnea among hospitalized patients. |
09:55 - 10:05 |
Oral presentation 7
Speaker: Dr. Janelle Yorke, University of Manchester, United Kingdom
Title: Evaluation of individual activity descriptors of the MRC dyspnoea scale |
10:05 - 10:15 |
Oral presentation 8
Speaker: Dr. Zainab Ahmadi, Lund University, Sweden
TItle: Is chronic breathlessness less recognized and treated compared with chronic pain?: A case-based randomized controlled trial |
10:15 - 10:25 |
Oral presentation 9
Speaker: Sara J. Abdallah, McGill University, Canada
Title: Psychological and neural factors influencing variability in response to opioid therapy for breathlessness |
10:25 - 10:35 |
Oral presentation 10
Speaker: Sara J. Abdallah, McGill University, Canada
Title: Is there a role for vaporized cannabis in the management of exertional breathlessness and exercise intolerance in COPD? |
10:35 - 11:20 |
Lightning Round Presentations: 2 slides in 2 minutes!
- Kathy M. Baker (Harvard Medical School, USA): Assessing dyspnea in ICU patients: An opportunity to improve care
- Kathy M. Baker (Harvard Medical School, USA): How we assess for dyspnea: Does "No" mean "Zero"?
- Dr. Margaret L. Campbell (Wayne State University, USA): Mild, moderate, and severe intensity cut-points for the respiratory distress observation scale: A receiver operating characteristics curve analysis
- Dr. Margaret L. Campbell (Wayne State University, USA): Trajectory of dyspnea and respiratory distress among patients in the last month of life
- Dr. Jennifer Stevens (Harvard Medical School, USA): Temporal patterns of dyspnea during the hospital stay
- Dr. Miriam J. Johnson on behalf of Ann Hutchinson (University of Hull, United Kingdom): Presentation to the emergency department by breathless patients: A qualitative study
- Dr. Magnus Ekstrom on behalf of Dr. David C. Currow (Lund University, Sweden): Missed opportunity? Worsening breathlessness as a harbinger of death: A cohort study
- Dr. Miriam J. Johnson on behalf of Ann Hutchinson (University of Hull, United Kingdom): Living with breathlessness: A systematic literature review and thematic synthesis
- Emilie Michalovic (McGill University, Canada): Breathlessness: A major barrier to participation in daily and social activities for adults living with COPD
- Emilie Michalovic (McGill University, Canada): Relief of breathlessness: Top healthcare and research priority for adults living with mild to very severe COPD
- Hayley Lewthwaite (University of South Australia, Australia): Prioritise symptoms, expectations and coping strategies in people with COPD: Delphi consensus of factors important to improve habitual behaviours
- Dr. Miriam J. Johnson (University of Hull, United Kingdom): Breathlessness and sexual activity in older adults: The Australian Longitudinal Study on Ageing
- Dr. Marie Williams (University of South Australia, Australia): Pulmonary rehabilitation with and without cognitive behavioral therapy for breathlessness: Pragmatic randomized controlled trial
- Dr. Rachael A. Evans (University Hospitals of Leicester NHS Trust, United Kingdom): Need for integrated symptom-based diagnostic pathways: Results from a pilot diagnostic cardio-respiratory breathlessness clinic
- Jacob Sandberg (Lund University, Sweden): Validation of the Dyspnea Exertion Scale of breathlessness in people with life-limiting illness
- Ann Norweg (New York University, USA): Minimum clinically important difference for the Dyspnea Management Questionnaire-Computer Adaptive Test (DMQ-CAT)
- Catherine Paquet (University of South Australia, Australia): Longitudinal changes in breathlessness assessed with the Dyspnoea-12 and Multidimensional Dyspnea Profile: Sub-analysis of a pragmatic randomised controlled trial
- Dr. Joanna C. Grogono (Oxford Brookes University, United Kingdom): Measuring dyspnea in chronic heart failure
- Dr. Alan Hamilton (Boehringer Ingelheim, Canada): Measuring breathlessness during in-clinic exercise testing and everyday activities
- Dr. Mathew Cherian (McGill University, Canada): Characteristics of dyspnea among adults with mild to moderate COPD and different exacerbation profiles: inferences from the CanCOLD study
|
11:20 - 12:35 |
Poster Viewing & Discussion |
12:35 - 13:35 |
LUNCH |
13:35 - 13:55 |
Speaker: Dr. Michele Schaeffer, University of British Columbia, Canada
Title: Management of Exertional Breathessness in Interstial Lung Disease: Role of Hyperoxia |
13:55 - 14:15 |
Speaker: Dr. Caroline Jolley, Kings College London, United Kingdom
Title: Chronic Breathlessness Service - The UK Experience |
14:15 - 14:35 |
Speaker: Dr. Cathy Simpson, INSPIRED COPD Outreach Program, Halifax, Canada
Title: An "INSPIRED" Approach to the Management of Breathlessness in Advanced Chronic Obstructive Pulmonary Disease |
14:35 - 14:55 |
Speaker: Dr. Marie Williams, University of South Australia, Australia
Title: How do Health Professionals Explain Chronic Breathlessness to their Patients? |
14:55 - 15:15 |
Speaker: Dr. Miriam Johnson, University of Hull, United Kingdom
Title: Patient and Carer Experience of Breathlessess |
15:15 - 15:35 |
Speaker: Dr. Steffen Simon, University Hospital Cologne, Germany
Title: Management of Episodic Breathlessness |
15:35 - 15:50 |
Coffee Break |
15:50 - 16:50 |
Roundtable Discussion on Research Priorities on Breathlessness |
16:50 - 17:00 |
Closing Remarks & Acknowledgements |